| Management domain | Practical approach for hEDS/HSD | Evidence strength / limitations | Supporting citations |
|---|---|---|---|
| Diagnosis / exclusion workup and role of genetic testing | Diagnose hEDS clinically using 2017-style criteria: confirm generalized joint hypermobility, assess systemic and musculoskeletal features, and explicitly exclude other heritable/acquired connective-tissue disorders and unusual skin fragility. Genetic testing is mainly used to identify alternative diagnoses rather than confirm hEDS, because validated hEDS biomarkers/genes are lacking. | Moderate support for exclusionary value of genetics, weak support for confirmation of hEDS itself. In one specialty cohort, 26.4% of patients meeting hEDS criteria had an alternative or additional diagnosis on genetic testing; however, no validated molecular biomarker confirms hEDS. | (pqac-00000000, pqac-00000003, pqac-00000004) |
| Education / activity modification | Educate patients about joint protection, pacing, avoiding end-range hyperextension, recognizing instability triggers, and balancing activity against fatigue/post-exertional symptom flares. Tailor advice to symptom pattern and affected joints. | Mostly expert review/consensus and observational evidence; few controlled trials. Helpful in practice but not strongly trial-validated. | (pqac-00000019, pqac-00000021, pqac-00000026) |
| Physical therapy / strengthening / proprioception / orthoses-compression | Refer to PT/OT focused on periarticular muscle strengthening, motor control, proprioception, and stability training; hydrotherapy may be useful. Closed-chain and low-impact exercise are often favored. Compression garments, insoles, and orthoses may help selected patients, especially for postural control or instability. | Low-to-moderate evidence overall. Pediatric systematic review found only 2 RCTs (n=86) with no clear superiority of tested PT approaches and no sham/no-treatment controls; pilot studies suggest orthoses/compression can improve postural stability; some pregnancy-related reviews cite RCTs supporting proprioception/stabilization approaches. | (pqac-00000019, pqac-00000020, pqac-00000021, pqac-00000025) |
| Dysautonomia / POTS nonpharmacologic measures | Use first-line conservative autonomic management when orthostatic intolerance/POTS is present: increased salt and water intake, compression, graded/modified exercise, withdrawal of aggravating medications, and symptom-adapted conditioning. In patients with post-exertional malaise, pacing and caution with exercise progression are advised. | Mostly extrapolated from POTS care and review-level evidence; direct hEDS-specific trials are limited. Mechanistic links between dysautonomia and hEDS symptoms are plausible but not fully established. | (pqac-00000008, pqac-00000010, pqac-00000019) |
| GI symptom management | Use a biopsychosocial GI approach; prioritize disorders of gut-brain interaction before labeling structural dysmotility. Optimize oral diet/oral supplements first, limit unnecessary invasive testing, reduce iatrogenic harm, and manage symptom clusters (e.g., behavioral/dietary strategies, antiemetics/prokinetics, gut-brain neuromodulators, psychosocial support). Assisted feeding should generally be reserved for objective malnutrition or severe dysmotility syndromes. | Moderate review support for management principles, but pathophysiology is uncertain and motility data are mostly retrospective/tertiary-center based. GI symptom prevalence is high (30%-96%), but true prevalence of structural dysmotility is unknown. | (pqac-00000008, pqac-00000009, pqac-00000010) |
| Pain management / multidisciplinary pain care | Prefer non-opioid multimodal pain care: PT/exercise, symptom-targeted pharmacology (e.g., some use of amitriptyline/NSAIDs), pacing, and multidisciplinary pain programs. Avoid chronic opioids where possible because they may worsen GI burden and outcomes. | Evidence is limited and heterogeneous; much guidance is consensus- or review-based. Psychological and physical approaches appear more promising when integrated in multidisciplinary programs than when used in isolation. | (pqac-00000008, pqac-00000012, pqac-00000019) |
| Psychological interventions | Consider CBT/related therapies, psychoeducation, ACT/DBT-informed approaches, and interdisciplinary pain programs, especially when pain-related fear, anxiety, depression, self-management problems, or illness uncertainty are prominent. | Low-quality evidence base. Scoping review identified only 10 mostly small cohort/case studies; later systematic review found 6 studies, with best results when psychological treatment was combined with physiotherapy/multidisciplinary care. More RCTs are needed. | (pqac-00000013, pqac-00000015) |
| Surgery considerations / evidence quality / complication rates | Reserve surgery for carefully selected indications after conservative care fails; counsel about tissue fragility, bleeding, delayed wound healing, infection risk, recurrent instability, and variable outcomes. Orthopedic procedures should be individualized and expectations tempered. | Evidence is weak: 2024 scoping review found only Level III-IV studies, no RCTs, and inconsistent outcomes. One retrospective review cited a 91% complication rate and infection rate >18-fold institutional baseline; some smaller series report benefit in selected procedures, but recurrence/failure remains a concern. | (pqac-00000022, pqac-00000024, pqac-00000026) |
| Pregnancy / childbearing management principles | Use individualized multidisciplinary perinatal planning addressing tissue fragility, mobility/joint instability, pain, dysautonomia/POTS, GI symptoms, mast-cell disease history, wound healing, pelvic health, anesthesia considerations, and postpartum recovery. | Moderate scoping-review/guideline support but limited high-quality primary evidence. Expert co-created guidance is available; a large international survey (947 respondents, 1338 pregnancies) reported higher-than-general-population rates of several complications, but survey design limits causal inference. | (pqac-00000009, pqac-00000014, pqac-00000020) |


*Table: This table summarizes current management approaches for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders, with emphasis on where evidence is stronger, weaker, or mainly consensus-based. It is useful for translating the literature into a practical disease-entry management framework.*